Synthesis 2003(1): 0107-0111
DOI: 10.1055/s-2003-36249
PAPER
© Georg Thieme Verlag Stuttgart · New York

Synthesis of AZT 5′-O-Hydrogen Phospholipids [1] and their Derivatives

Qiang Xiaoa, Jing Sunb, Qi Suna, Yong Ju*a, Yu-fen Zhao*a, Yu-xin Cuib
a The Key Laboratory of Bioorganic Phosphorus Chemistry, Ministry of Education, Department of Chemistry, School of Life Sciences and Engineering, Tsinghua University, Beijing 100084, P. R. China
b National Research Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100083, P. R. China
Fax: +86(10)62781695; e-Mail: juyong@tsinghua.edu.cn; e-Mail: yfzhao@tsinghua.edu.cn;
Further Information

Publication History

Received 10 September 2002
Publication Date:
18 December 2002 (online)

Abstract

A series of AZT 5′-O-hydrogen phospholipids 5a-e were synthesized by a tandem transesterification of diphenyl phosphite (DPP) with AZT and a long-chain alcohol. This method has the merits of easy operation and high yields. The corresponding phosphonates, phosphorothionates and phosphoroselenoates of 5d and 5e and the phosphoramidates conjugated with l-amino acid methyl ester 9a and 9b were also synthesized.

    References

  • 1 Preliminary communications: Xiao Q. Sun J. Ju Y. Zhao YF. Cui YX. Tetrahedron Lett.  2002,  43:  5281 
  • 2a Kohl NE. Emini EA. Schleif WA. Davis LJ. Heimbach JC. Dixon RAF. Scolnick EM. Sigal IS. Proc. Natl. Acad. Sci. U.S.A.  1988,  85:  4686 
  • 2b Jonckbeere H. Anne J. DeClercq E. Med. Res. Rev.  2000,  20:  129 
  • 2c Kempf DJ. Sharm HL. Curr. Pharm. Des.  1996,  2:  225 
  • 3a Coates JA. Commack N. Jenkinson HA. Mutton IM. Pearson BA. Storer R. Cameron JM. Penn CR. Antimicrob. Agents. Chemother.  1992,  36:  202 
  • 3b Mitsuya H. Broder S. Proc. Natl. Acad. Sci. U.S.A.  1986,  6:  1911 
  • 3c Wiebe LR. Knaus EE. Adv. Drug. Deliv. Rev.  1999,  39:  63 
  • 3d Yarchoan R. Mitsuya H. Thomas RV. Johns DG. Border S. Science  1989,  245:  412 
  • 4 Mitsuya H. Weinhold KJ. Furman PA. Clair MH. Lehrman SN. Gallow RC. Bologonosi D. Barry DW. Border S. Proc. Natl. Acad. Sci. U.S.A.  1985,  82:  7096 
  • 5 Tan X. Chu CC. Boudinot FD. Adv. Drug. Deliv. Rev.  1999,  39:  117 
  • 6 Martin JL. Brown CE. Matthew-Davis N. Reardon JE. Antimicrob. Agents. Chemother.  1994,  38:  2743 
  • 7a Johnson MA. Fridland A. Mol. Pharmacol.  1989,  36:  291 
  • 7b Johnson MA. Ahluwalia G. Connelly MC. Cooney DA. Broder S. Johns DG. Fridland A. J. Biol. Chem.  1988,  263:  15354 
  • 8 Parang K. Wiebe LI. Knaus EE. Curr. Med. Chem.  2000,  7:  995 
  • 9 Cardona VMF. Ayi AI. Aubertin AM. Guedj R. Antiviral Res.  1999,  42:  189 
  • 10a Machado J. Salomon H. Oliveira M. Nucleosides Nucleotides  1999,  18:  901 
  • 10b Tarussova NB. Kukhanova MK. Krayevsky AA. Karamov EK. Lukashov VV. Kornilayeva GB. Rodina MA. Galegov GA. Nucleosides Nucleotides  1991,  10:  351 
  • 11 Yurin O. Kravtchenko A. Serebrovskaya L. Golochvastova E. Burova N. Voronin E. Pokrovsky V. AIDS  1998,  12:  240 
  • 12 Ji CJ. Xue CB. Zeng JN. Zhao YF. Synthesis  1988,  444 
  • 13 Boal JH. Iyer RP. Egan W. Nucleosides Nucleotides  1993,  12:  1075 
  • 14 Beaucage SL. Iyer RP. Tetrahedron  1993,  49:  6123 
  • 15 Nurinen EJ. Mattinen JK. J. Chem. Soc., Perkin. Trans. 2  1998,  1621 
  • 16 Stawinski J. In Handbook of Organophosphorus Chemistry   Engel R. Marcel Dekker; New York: 1992.  p.377-434  
  • 17 Garegg PJ. Regberg T. Stawinski J. Stomberg R. Chem. Scr.  1986,  26:  59 
  • 18 Marugg JE. Tromp M. Kuyl-Yeheskiely E. van der Marel GA. van Boom JH. Tetrahedron Lett.  1986,  27:  2661 
  • 19 Hall RH. Todd A. Webb RF. J. Chem. Soc.  1957,  3291 
  • 20 Kers A. Kers I. Stawinski J. Sobkowski M. Kraszewski A. Synthesis  1995,  427 
  • 21 Jankowska J. Sobkowski M. Stawinski J. Kraszewski A. Tetrahedron Lett.  1994,  35:  3355 
  • 22 Iyer VV. Griesgraber GW. Radmer MR. McIntee EJ. Wagner CR. J. Med. Chem.  1999,  42:  5188 
  • 23 Lindh I. Stawinski J. J. Org. Chem.  1989,  54:  1338